Table 4 Acute toxicity as a function of patient and disease characteristics
Patient characteristics | Acute GI toxicity | Acute hematological toxicity | Acute epatobyliary toxicity | Acute pancreatic toxicity | Acute renal toxicity | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
total | G0-G1 | ≥G2 | G0-G1 | ≥G2 | G0-G1 | ≥G2 | G0-G1 | ≥G2 | G0-G1 | ≥G2 | |
Total | 29 | 26 | 3 | 21 | 8 | 29 | 0 | 29 | 0 | 29 | 0 |
Median age (y) | 65.1 | 66.1 | 54 | 67.9 | 57.6 | 65.1 | 0 | 65.1 | 0 | 65.1 | 0 |
Primary prostate cancer | 4 | 3 | 1 | 3 | 1 | 4 | 0 | 4 | 0 | 4 | 0 |
Nodal recurrence of prostate cancer | 17 | 17 | 0 | 16 | 1 | 17 | 0 | 17 | 0 | 17 | 0 |
Postoperative endometrial cancer | 3 | 3 | 0 | 1 | 2 | 3 | 0 | 3 | 0 | 3 | 0 |
Primary cervical cancer | 5 | 3 | 2 | 1 | 4 | 5 | 0 | 5 | 0 | 5 | 0 |
History of abdominal surgery | 15 | 15 | 0 | 12 | 3 | 15 | 0 | 15 | 0 | 15 | 0 |
History of prior RT | 13 | 13 | 0 | 12 | 1 | 13 | 0 | 13 | 0 | 13 | 0 |
Paraaortic RT | 10 | 10 | 0 | 9 | 1 | 10 | 0 | 10 | 0 | 10 | 0 |
Paraaortic + pelvic nodes RT | 19 | 16 | 3 | 12 | 7 | 19 | 0 | 19 | 0 | 19 | 0 |
Intracavitary brachytherapy | 5 | 5 | 0 | 1 | 4 | 5 | 0 | 5 | 0 | 5 | 0 |
Concurrent chemotherapy | 7 | 6 | 1 | 2 | 5 | 7 | 0 | 7 | 0 | 7 | 0 |